American Headache Society published recommendations for when neuroimaging is most beneficial
Not all patients who experience a migraine should undergo neuroimaging, according to recommendations released by the American Headache Society (AHS).
If a patient presents with a headache consistent with migraine, but he or she also has a normal neurological exam without any other points of concern, additional neuroimaging isn’t necessary. Only patients who experience other factors that point to potentially negative underlying problems should receive CT or MRI scanning.
These recommendations were published recently in a study in Headache. They were based on a review of 23 studies that included adults who pursued outpatient treatment for migraine and who received either MRI or CT scans.
Patients in the studies who had headaches consistent with migraine demonstrated no differences to patients in the general population, according to the multi-institution team that reviewed the existing literature. Existing literature supports that finding, the team said. Consequently, the AHS recommends neuroimaging in these patients isn’t necessary.
However, there are some circumstances in which patients with headaches consistent with migraine should receive further neuroimaging. Additional imaging should be considered in these situations:
Overall, the team said, following these recommendations could reduce the overutilitation of neuroimaging. But, they noted these recommendations do not mandate any particular course of medical care, and they are not intended to replace professional judgement.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.